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SUMMARY 
Fifty four schizophrenic patients, diagnosed as per Research Diagnostic Criteria, were studied for immu-
noglobulin profiles. The schizophrenics were subdivided into paranoid and non-paranoid groups and their immu-
noglobulin profiles were compared with those of normals. There was no significant difference between normals and 
schizophrenic groups. Duration of illness, previous episodes of schizopnrenia, family history of schizophrenia 
severity of psychosis and duration of hospital stay had no influence on serum IgG, IgA and IgM in schizophrenics. 
The results are discussed in the light of existing literature on immunoglobulin alterations in schizophrenia. 
Various immunological factors have 
been studied in schizophrenia and the etio-
logy of schizophrenia has been explained 
on the basis of altered immunological func-
tioning. The studies on serum immunoglo-
bulins revealed uncorroborated and non-
specific alterations in schizophrenic pa-
tients. The alteration of the immunoglobu-
lin levels was attributed to immunological 
dysfunctioning in schizophrenia (Strahile-
vitz et al 1976, Solntseva and Faktor 1976, 
Pulkkinen 1977, Strahilevitz 1979 and Ti-
wari et al 1984). On the other hand, the ele-
vation of immunoglobulin levels was consi-
dered as non-specific alteration as similar 
changes were also seen in non-schizoph-
renic psychiatric patients (Solomon et al 
1969, Galli et al 1972, Noeva and Mano-
lova 1976 and Fontana et al 1980). 
The present study was carried out with 
the objective of estimating the immunoglo-
bulin levels (serum IgG, IgA and IgM) in 
schizophrenics and to find out their rela-
tionship with (a) duration of illness, (b) se-
verity of psychosis, (c) previous episodes of 
schizophrenia, (d) family history of schi-
zophrenia and (e) duration of hospital stay. 
Material and Methods 
Fifty four patients, diagnosed as schi-
zophrenia on the basis of Research Diag-
nostic Criteria (Spitzer et al 1977), were ad-
mitted to psychiatric wards at NIMHANS, 
Bangalore. The patients were divided into 
paranoid and non-paranoid schizophrenic 
groups according to Research Diagnostic 
Criteria (Spitzer et al 1977). The age 
ranged between 18-45 years, the mean ages 
in paranoid and non-paranoid schizophren-
ic groups were 28 and 27 respectively. The 
exclusion criteria specific for the study, 
were female patients, poor nutrition, evid-
ence of any physical illness, history of rec-
ent infections, prior neuroleptic treatment 
or electroconvulsive therapy during one 
year before the present admission, alcohol 
or drug dependence, organ transplantation 
or blood transfusion and history of recent 
vaccination. 
The control sample consisted of thirty 
healthy male normal volunteers with no fam-
ily history or past history of schizophrenia. 
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Their mean age was 27 years. The same 
exclusion criteria used for patients sample, 
were applied to the controls before assess-
ment. 
Assessment of Patients: The patients' demo-
graphic variables and illness variables were 
recorded. The severity of psychosis was 
measured on Brief Psychiatric Rating Scale 
(B.P.R.S.) of Overall and Gorham (1962). A 
thorough physical examination and labora-
tory investigations were done every week 
to exclude the patients developing physical 
illness, especially infections during the ho-
spital stay. The patients were kept in the 
hospital till their total B.P.R.S. scores de-
creased by 75 % and were discharged after 
significant clinical improvement as assessed 
by two psychiatrists independently. 
The patients were not given neurolep-
tics on the day of admission and about 6 ml 
of blood was drawn from the patients 
around 8 A.M. on the next day. The serum 
was separated from the blood immediately 
and the samples were store in deep freeze 
at - 20 ° C until the serum samples were as-
sayed in batches (not beyond 3 months). 
Serum immunoglobulins IgG, IgA and 
IgM were assayed by measuring the anti-
gen-antibody reaction by kinetic fixed-
time analysis of Neumann et al (1978). The 
assays were performed with the use of com-
mercial test kits obtained from M/s Boeh-
ringer Manheim (West Germany). 
Results 
The socio-demographic variables and 
illness variables were not significantly dif-
ferent between paranoid and non-paranoid 
schizophrenia groups (Table). The mean 
serum IgG, IgA and IgM levels were not 
significantly different among the three 
groups, i.e., paranoid, non-paranoid schi-
zophrenic groups and normal controls. 
The severity of psychosis, as measured 
on B.P.R.S. also showed no correlation to 
Table 
Socio-demographic and illness variables 
Paranoid Non Paranoid 
Variables Schizophrenia Schizophrenia 
(N = 31) (N = 23) 
1. Domicile: 
Urban 6 5 
Rural 25 18 
2. Family History of 
Schizophrenia: 
Positive 6 6 
Negative 25 17 
3. Previous episodes 
of Schizophrenia: 
Positive 5 5 
Negative 26 18 
4. Duration of illness : 
Less than 
6 months 20 11 
More than 
6 months 11 12 
5. Duration of 
hospital stay (days): 
Mean 28.84 26.65 
S.D. 15.93 11.13 
any of the three immunoglobulins in both 
the patient groups. Similarly, duration of ill-
ness, previous episodes of schizophrenia, 
family history of schizophrenia and dura-
tion of hospital stay had no relation to 
serum immunoglobulins in schizophrenic 
patients. 
Discussion 
The immunoglobulin profiles of schi-
zophrenic patients in the present study do 
not differ from those of normal controls. 
Though the method of estimation of im-
munoglobulins is different from radial im-
muno-diffusion used in most of the previ-
ous investigations, the limit of estimation of 
immunoglobulins has been reported to be 
same (Davis and Monto 1977). The nega-
tive findings are consistent with those of 
Arko and Parsic (1969), Hendrie et al 
(1975), Torrey et al (1978) and Sugerman 
et al (1982). 
Solomon et al (1969) found elevated 
levels of serum IgA and IgM in both schizo-
phrenic and non-schizophrenic psychiatric I. V. L. NARASIMHA RAO ET AL  327 
patients, and concluded that the alteration 
was non-specific in schizophrenia. Noeva 
and Manolova (1976) found increasing le-
vels of serum IgG in patients with schi-
zophrenia, manic depressive psychosis and 
disseminated sclerosis, and emphasized the 
non-specificity of the alteration of immu-
noglobulins in schizophrenia. Similarly 
Fontana et al (1980) reported elevation of 
serum IgG and IgM concentrations in both 
schizophrenics and patients with affective 
disorder. They considered the alteration 
was non-specific as similar abnormality was 
also observed in the hospital control popu-
lation. The above observations conclusively 
indicate that the alteration of immunoglo-
bulins in schizophrenia was inconsistent 
and highly non-specific. 
Amkraut et al (1973) contrary to the ne-
gative findings of the present study, found 
significant elevation of serum IgG, IgA and 
IgM levels in schizophrenic patients. Stra-
hilevits and Davis (1970) found elevated le-
vels of serum IgA in schizophrenic patients, 
but later were able to replicate their fin-
dings only for female and black schizoph-
renic patients (Strahilevitz et al 1976). Bock 
et al (1970) found low IgM levels in schi-
zophrenic patients when compared with 
normal controls. These studies, though 
showed significant alteration of immuno-
globulin levels in schizophrenic patients, do 
not add much to the understanding of the 
possible relation to schizophrenic illness, as 
the nature of alteration of immunoglobu-
lins was inconsistent in various studies. 
The illness variables, such as duration of 
illness, severity of psychosis, previous epi-
sodes of schizophrenia and family history of 
schizophrenia in the present study showed 
no influence on immunoglobulin levels. 
Persic et al (1973) found elevated levels of 
serum IgA in acute schizophrenics and de-
creased levels of serum IgM in chronic schi-
zophrenics. Vecchio et al (1975) found ele-
vated levels of serum IgA in schizophrenics 
with family history of schizophrenia. Pulk-
kinen (1977) reported serum IgA and IgG 
levels, higher than average at the beginning 
of the treatment, predict a short hospital 
stay. On the contrary, the present study ob-
served no relationship between the immu-
noglobulin levels and duration of hospital 
stay. 
The present study does not show evid-
ence for abnormal immune functioning in 
schizophrenia, and the interpretation of 
findings in other reports remains largely 
speculative as the studies on serum immu-
noglobulins showed inconsistent and non-
specific changes with lack of concordance 
among various reports. 
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